| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/14/2004 | CN1488943A Method for preparing diaghostic reagent of human immunodeficiency virus antibody |
| 04/14/2004 | CN1488942A Curing enzyme conjugate for enzyme-linked immunosorbent test and its preparation |
| 04/14/2004 | CN1488941A Test paper for detecting morphine |
| 04/14/2004 | CN1488936A Medium-stable reagent composition and method for electrochemical analysis matter detection |
| 04/14/2004 | CN1488907A Refrigerator fruit-vegetable freshness prompter and method for analysing and processing sighals thereof |
| 04/14/2004 | CN1488766A Biochip |
| 04/14/2004 | CN1488646A SARS virus S protein and N protein fusion protein, and preparation and use thereof |
| 04/14/2004 | CN1488645A Specific antibody IgY for anti SARS virus, and preparing method thereof and composition containing same and its use |
| 04/14/2004 | CN1145897C Digital image measuring method and equipment of triaxle testing sample soil deformation |
| 04/14/2004 | CN1145798C In vitro method for determining presence of hepatocellular carcindoma |
| 04/14/2004 | CN1145797C Method of determining ceruloplasm concertration in blood cake and hepatolenticular degeneration disease screering reagent box and deagnostic reagent |
| 04/14/2004 | CN1145796C Test strip deive with lid-provided pretreatment portion and measuring method |
| 04/14/2004 | CN1145795C Measurement of stress levels in polymeric compositions |
| 04/14/2004 | CN1145794C Method for marking liquids with at least two marker substances and method for detecting them |
| 04/14/2004 | CN1145704C Mesoscale polynucleotide amplification device |
| 04/14/2004 | CN1145693C Amino-terminally truncated MCP-2 as chemokine antagnosits |
| 04/14/2004 | CN1145639C Subunit respiratory syncytial virus vaccine preparation |
| 04/14/2004 | CN1145590C Water treatment controlling system using fluorescence analyzer |
| 04/14/2004 | CN1145532C Metal-foil sealing box for agglutination reaction and lining cover for same |
| 04/14/2004 | CA2444179A1 Method for determining multimers of plasma proteins |
| 04/13/2004 | US6721663 Method for manipulating protein or DNA sequence data in order to generate complementary peptide ligands |
| 04/13/2004 | US6721586 Percutaneous biological fluid sampling and analyte measurement devices and methods |
| 04/13/2004 | US6721310 Multiport non-blocking high capacity ATM and packet switch |
| 04/13/2004 | US6720960 Method for the analysis and evaluation of at least three-dimensional specimen data |
| 04/13/2004 | US6720472 Therapy for use in the treatment of obesity; obtain mammal, administer dietetic modulating agent, monitor adjustment in weight |
| 04/13/2004 | US6720431 Solvent extraction |
| 04/13/2004 | US6720408 Generation of preferential nucleotide sequences library; obtain nucleotide sequences, denature, hybridize to primers, remove and recover nucleotide sequences expressing signal |
| 04/13/2004 | US6720193 Determining concentration of preferential particles in sample; obtain sample, apply to column, monitor column for signal, determine concentration preferential particle in sample |
| 04/13/2004 | US6720192 Screening for analytes using labeled receptors |
| 04/13/2004 | US6720190 Using frontal chromatography in combination with mass spectrometry to identify and rank those members of the library that bind to a target receptor. |
| 04/13/2004 | US6720189 Lower serum bilirubin levels generally indicating increased risk and higher levels a decreased risk. |
| 04/13/2004 | US6720188 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample |
| 04/13/2004 | US6720186 Useful for synthesizing, screening, and characterizing combinatorial catalyst libraries |
| 04/13/2004 | US6720185 Method for analysis of the textural structure of food of a multi-component dispersion system |
| 04/13/2004 | US6720181 Ubiquitin ligases as therapeutic targets |
| 04/13/2004 | US6720177 Porous semiconductor-based optical interferometric sensor |
| 04/13/2004 | US6720166 Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 04/13/2004 | US6720162 Phosphorylation |
| 04/13/2004 | US6720161 Immobilized substrate, separation gels and method for detecting enzymatic activity |
| 04/13/2004 | US6720160 Detecting infection in milk of mammals; obtain milk sample, expose to antibodies, detect bound antibodies, presence of bound antibodiy inicates infection |
| 04/13/2004 | US6720158 Splice variants of BRCA1 |
| 04/13/2004 | US6720157 Chips having elevated sample surfaces |
| 04/13/2004 | US6720156 Monoclonal antibody; for use in the treatment, diagnosis, screening, and imaging of joint defects |
| 04/13/2004 | US6720154 Identifying a drug that enhances the ability of adjacent stat protein dimers to interact |
| 04/13/2004 | US6720153 Luciferase reporter bioassay of parathyroid hormone compounds |
| 04/13/2004 | US6720152 Diagnosis of histoplasmosis using antigens specific for H. capsulatum |
| 04/13/2004 | US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer |
| 04/13/2004 | US6720143 Determinating nucleotide polymorphism |
| 04/13/2004 | US6720141 Diagnostics and therapeutics for restenosis |
| 04/13/2004 | US6720138 Method of preparing a standard diagnostic gene transcript pattern |
| 04/13/2004 | US6719980 Vaccines, diagnostic kits, veterinary medicine |
| 04/13/2004 | US6719978 Virus-like particles for the induction of autoantibodies |
| 04/13/2004 | US6719923 Comprises cellulose acetates as polymer, 1,4-dioxane, 4-hydroxymethylpentanone, and/or ethyl acetate as solvent, and n-octanol and/or 2-methyl-2,4-pentanediol as pore former; for measuring blood glucose concentration/hematocrit |
| 04/13/2004 | US6719887 Biosensor |
| 04/13/2004 | US6719771 Blood sampling device |
| 04/13/2004 | US6719682 Electronic spindle for using centripetal acceleration to drive fluid movement in a microfluidics system |
| 04/13/2004 | US6719184 Nondestructive inspection method |
| 04/13/2004 | US6719172 Pepper agent system |
| 04/13/2004 | US6718819 Oil quality sensor system, method and apparatus |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/13/2004 | CA2195076C Process for modifying the stability of antibodies |
| 04/13/2004 | CA2176781C Electrochemical gas sensor assembly |
| 04/13/2004 | CA2055695C Ca 195-like immunoreactive antigen from human amniotic fluid |
| 04/08/2004 | WO2004029630A1 N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
| 04/08/2004 | WO2004029629A1 N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses |
| 04/08/2004 | WO2004029628A1 Detection of correctly folded hla class 1 complexes by elisa |
| 04/08/2004 | WO2004029627A1 A method for detecting, screening and/or monitoring a cancer in an individual |
| 04/08/2004 | WO2004029626A1 Regulation of human p2y15 g protein-coupled receptor |
| 04/08/2004 | WO2004029625A2 Detecting molecular binding by monitoring feedback controlled cantilever deflections |
| 04/08/2004 | WO2004029624A1 Diagnostic and examination method for eating disorder |
| 04/08/2004 | WO2004029623A1 Method and device for diagnosing oncological diseases |
| 04/08/2004 | WO2004029622A2 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases |
| 04/08/2004 | WO2004029621A2 Tcell mediator/modulator assay based upon tcell restricted transgenic mouse |
| 04/08/2004 | WO2004029620A2 Screening method involving transfected primary t cells |
| 04/08/2004 | WO2004029619A1 Analyzing tool |
| 04/08/2004 | WO2004029617A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
| 04/08/2004 | WO2004029616A2 Methods for detecting prostate cancer |
| 04/08/2004 | WO2004029615A1 Gasoline the identification system and method for identifying gasoline type |
| 04/08/2004 | WO2004029613A1 Method of measuring glycoprotein |
| 04/08/2004 | WO2004029611A1 Mesoporous platinum electrode and method for detecting biochemical substrate using the mesoporous platinum electrode |
| 04/08/2004 | WO2004029610A1 Switching circuit arrangement comprising an integrated reference electrode and method for producing said switching circuit arrangement |
| 04/08/2004 | WO2004029607A1 Alcohol concentration detector, method of detecting alcohol concentration therewith and process for producing alcohol concentration detection sensor |
| 04/08/2004 | WO2004029605A1 Apparatus and method for measuring reaction result of samples on biosensor |
| 04/08/2004 | WO2004029602A2 Phased micro analyser |
| 04/08/2004 | WO2004029596A1 Diffraction-based diagnostic devices |
| 04/08/2004 | WO2004029592A1 Method and device for continuously conducting a fuel preparation process, especially for a diesel engine, by mixing the constituents thereof on-line |
| 04/08/2004 | WO2004029583A2 Methods of secretory vimentin detection and modulation |
| 04/08/2004 | WO2004029582A2 Surface plasmon resonance systems and methods having a variable charge density layer |
| 04/08/2004 | WO2004029576A2 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 04/08/2004 | WO2004029575A2 Methods for diagnosing htlv-i-mediated diseases |
| 04/08/2004 | WO2004029573A2 Low power gas leak detector |
| 04/08/2004 | WO2004029298A2 Mitochondrial dna autoscoring system |
| 04/08/2004 | WO2004029295A1 Method for diagnosis of cancer |
| 04/08/2004 | WO2004029293A1 Method of diagnosing integration dysfunction syndrome using blood |
| 04/08/2004 | WO2004029291A1 Method of evaluationg canceration degree of mammal-origin specimen |
| 04/08/2004 | WO2004029285A2 Methods for detecting endocrine cancer |
| 04/08/2004 | WO2004029280A2 Anti-hla assay and methods |
| 04/08/2004 | WO2004029244A1 Animal cells having chimeric receptor and utilization thereof |
| 04/08/2004 | WO2004029243A1 Method of predicting genetic risk for hypertension |
| 04/08/2004 | WO2004029238A1 Human tissue kallikrein-specific immunoglobulin, immunologic formulation comprising the immunoglobulin and related diagnostic kit for the diagnosis of cerebral ischemia |